Categories AlphaGraphs, Earnings, Retail
Michael Kors’ stock tanks 12% after Q2 revenues miss estimates
Michael Kors Holdings Limited’s (KORS) shares dropped over 12% during premarket hours on Wednesday after the company topped market estimates on earnings for the second quarter of 2019 but missed the mark on revenues.
Total revenues grew 9.3% to $1.25 billion from the year-ago period, including a $116.7 million contribution from Jimmy Choo, but came in shy of the Street estimate of $1.26 billion.
Reported net income dropped to $137.6 million or $0.91 per share from $202.9 million or $1.32 per share in the prior-year period. Adjusted net income was $192.5 million or $1.27 per share. Analysts had estimated earnings of $1.10 per share.
Michael Kors brand revenues fell 0.8% but came in line with the company’s expectations. Comparable store sales, which were down in the low single digits, were also in line with the firm’s expectations.
Jimmy Choo posted better-than-expected revenues, which were helped by strength in footwear. The company saw revenue declines across its Retail, Wholesale and Licensing segments. Inventory dropped 11% compared to the prior-year period.
During the quarter, Michael Kors announced an agreement to acquire Gianni Versace SPA for $2.1 billion. The transaction is expected to close in the fourth quarter of 2019 and following the acquisition, Michael Kors will change its name to Capri Holdings Limited and operate under the ticker CPRI.
Michael Kors to continue shopping spree with Versace, after Jimmy Choo
For the full year of 2019, Michael Kors is raising its outlook for adjusted EPS by $0.05 to a range between $4.95 and $5.05, reflecting better-than-expected Q2 performance for the Michael Kors and Jimmy Choo brands. Revenue is expected to be around $5.12 billion, including between $580 million and $590 million of incremental Jimmy Choo revenue.
For the third quarter of 2019, Michael Kors expects total revenue to be about $1.46 billion, including approx. $165 million of incremental revenue from Jimmy Choo. Diluted EPS is expected to be $1.52 to $1.57, which includes approx. $0.04 to $0.06 of accretion from Jimmy Choo.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on